Panacea Index Logo

Command Palette

Search for a command to run...

The role of melatonin treatment in chronic kidney disease.

Frontiers in bioscience (Landmark edition)
January 1, 1970
Marije Russcher et al. (6 authors)
Journal ArticleReviewHuman Study
Study Details

Study Goal

The researchers aimed to evaluate the therapeutic benefits of melatonin in addressing sleep disturbances, blood pressure alterations, and oxidative stress in patients with Chronic Kidney Disease (CKD).

Results Summary

The study found that melatonin treatment improved sleep disorders in CKD patients, had beneficial effects on blood pressure, and provided protection against oxidative stress and inflammation in renal disorders. Controlled trials supported these findings.

Population

Patients with Chronic Kidney Disease (CKD), particularly those on hemodialysis.

Effective Dosage

Not specified

Duration

Not specified

Interactions

None mentioned

Extracted Claims (3)
InterventionDirectionEndpointPopulationDosageImpactClaim #
melatonin treatment
decrease
sleep disorders related to chronic kidney disease
patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis
-
therapeutic benefit
#1
melatonin
decrease
blood pressure alterations
CKD states
-
beneficial effect
#2
melatonin
decrease
oxidative stress and inflammation
renal disorders
-
protection
#3
Abstract

The pineal hormone melatonin plays a major role in circadian sleep-wake rhythm. Patients with Chronic Kidney Disease (CKD), especially those who are on hemodialysis, frequently suffer from sleep disturbances. In this review an overview is given of the classification of stages of chronic kidney disease, followed by a presentation of the circadian rhythm disorders in renal disease involving sleep disturbances in relation to melatonin deficiency. The therapeutic benefit of melatonin treatment in sleep disorders related to chronic kidney disease including the controlled trials solving this topic, is described. Furthermore, the beneficial effect of melatonin on blood pressure alterations in CKD states and the protection of melatonin in oxidative stress and inflammation in renal disorders are explored. Finally a hypothetic model is described for the relation between circadian rhythm disorders and CKD.

Medical Subject Headings (MeSH)
Blood PressureChronobiology DisordersChronotherapyHumansInflammation MediatorsKidney Failure, ChronicMelatoninModels, BiologicalOxidative StressRenal DialysisRenal Insufficiency, ChronicSleep Wake DisordersStress, Psychological
Study Links
Quality Scores
SafetyNot Assessed
Efficacy75/10
Quality80/10
Citation Metrics
Total Citations38
Citations/Year2.9
Relative Citation Ratio1.39
NIH Percentile62.5%
Research Impact Scores
APT Score0.75
Weight Score1.82
Normalized Score0.66
Related Supplements
The role of melatonin treatment in chronic kidney disease. | Panacea Index